{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:51:58Z","timestamp":1781081518963,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":14,"publisher":"Springer US","isbn-type":[{"value":"9781071607701","type":"print"},{"value":"9781071607718","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0771-8_16","type":"book-chapter","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T07:02:49Z","timestamp":1598857369000},"page":"221-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy"],"prefix":"10.1007","author":[{"given":"Sara","family":"Aguti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","volume":"379","author":"MD Benson","year":"2018","unstructured":"Benson MD et al (2018) Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 379:22\u201331","journal-title":"N Engl J Med"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/nat.2017.0665","volume":"27","author":"A Aartsma-Rus","year":"2017","unstructured":"Aartsma-Rus A (2017) FDA approval of Nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides. Nucleic Acid Ther 27:67\u201369","journal-title":"Nucleic Acid Ther"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/nat.2016.0657","volume":"27","author":"A Aartsma-rus","year":"2017","unstructured":"Aartsma-rus A, Krieg AM (2017) FDA approves eteplirsen for duchenne muscular dystrophy: the next chapter in the Eteplirsen saga. Nucleic Acid Ther 27:1\u20133","journal-title":"Nucleic Acid Ther"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1742-4658.2009.06908.x","volume":"276","author":"SM Cerritelli","year":"2009","unstructured":"Cerritelli SM, Crouch RJ (2009) Ribonuclease H: the enzymes in eukaryotes. FEBS J 276:1494\u20131505","journal-title":"FEBS J"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1016\/S0021-9258(19)85268-7","volume":"268","author":"BP Moniass","year":"1993","unstructured":"Moniass BP et al (1993) Evaluation of 2 \u2032 modified oligonucleotides containing 2 \u2032 -deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268:14514\u201314522","journal-title":"J Biol Chem"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","volume":"379","author":"D Merrill","year":"2018","unstructured":"Merrill D et al (2018) Inotersen treatment for patients with hereditary transthyretin Amylodosis. N Engl J Med 379:22\u201331","journal-title":"N Engl J Med"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll JB et al (2011) Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin. Mol Ther 19:2178\u20132185","journal-title":"Mol Ther"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.omtn.2017.07.006","volume":"8","author":"E Marrosu","year":"2017","unstructured":"Marrosu E, Ala P, Muntoni F, Zhou H (2017) Gapmer antisense oligonucleotides suppress the mutant allele of COL6A3 and restore functional protein in Ullrich muscular dystrophy. Mol Ther Nucleic Acids 8:416\u2013427","journal-title":"Mol Ther Nucleic Acids"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/hum.2012.109","volume":"23","author":"F Gualandi","year":"2012","unstructured":"Gualandi F et al (2012) Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy. Hum Gene Ther 23:1313\u20131318","journal-title":"Hum Gene Ther"},{"key":"16_CR10","first-page":"1","volume":"3","author":"S Noguchi","year":"2014","unstructured":"Noguchi S, Ogawa M, Kawahara G, Malicdan MC, Nishino I (2014) Allele-specific gene silencing of mutant mRNA restores cellular function in Ullrich congenital muscular dystrophy fibroblasts. Mol Ther 3:1\u20137","journal-title":"Mol Ther"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1242\/jcs.169748","volume":"128","author":"M Cescon","year":"2015","unstructured":"Cescon M, Gattazzo F, Chen P, Bonaldo P (2015) Collagen VI at a glance. J Cell Sci 128:3525\u20133531","journal-title":"J Cell Sci"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.22283","volume":"69","author":"AR Foley","year":"2011","unstructured":"Foley AR (2011) Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. Ann Neurol 69:206\u2013211","journal-title":"Ann Neurol"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ana.22087","volume":"68","author":"L Brin","year":"2010","unstructured":"Brin L et al (2010) Early onset collagen VI myopathies: genetic and clinical correlations. Ann Neurol 68:511\u2013520","journal-title":"Ann Neurol"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1212\/01.wnl.0000307749.66438.6d","volume":"70","author":"D Hicks","year":"2008","unstructured":"Hicks D, Fiorillo C, Sutton R, Lochmu H (2008) A refined diagnostic algorithm for Bethlem myopathy. Neurology 70:1192\u20131199","journal-title":"Neurology"}],"container-title":["Methods in Molecular Biology","Gapmers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0771-8_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T01:52:34Z","timestamp":1617069154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0771-8_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071607701","9781071607718"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0771-8_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}